Law360, New York (August 19, 2010) -- A federal judge has ruled that Sanofi-Aventis’ patent covering prostate treatment Uroxatral (Alfuzosin Hydrochloride) is valid and infringed by proposed generic versions from Aurobindo Pharma Ltd. and Torrent Pharma Inc.
For detailed report visit
http://health.law360.com/registrations/user_registration?article_id=187948&concurrency_check=false
No comments:
Post a Comment